Jalen Hurts Blood Clot: Eagles Not Planning Injured Reserve, Seeking Medical Opinions

The Philadelphia Eagles are not planning to place quarterback Jalen Hurts on injured reserve following the discovery of a superficial blood clot. The team is seeking additional medical opinions and believes the condition is treatable. Treatment options range from anti-inflammatory medications to blood thinners depending on the clot's severity, with a minimum six-week anticoagulant course as a possible path. The timeline for Hurts' return remains undetermined and will be guided by his medical team.

According to people with knowledge of the situation, the Eagles have no intention of moving Hurts to injured reserve, despite the quarterback remaining out of action for an unspecified period while dealing with a blood clot near the surface. Placing him on injured reserve — a move that carries a four-week minimum absence — has not come up in any team discussions, per sources. Both the quarterback's physical condition and the pursuit of further specialist assessments remain at the centre of ongoing discussions between Hurts and the Eagles organization. Hurts is weighing treatment options after doctors indicated the blood clot responds to medical intervention, according to people familiar with the situation. Physicians overseeing Hurts's recovery hold authority over any timetable for his return to the field, and the Eagles have indicated they will defer to that guidance. Placing Hurts on injured reserve remains an option, with the ultimate call depending on where the medical picture points. Anticoagulant medication — the class of drugs widely referred to as blood thinners — serves as the standard treatment approach for the majority of blood clot cases. Athletes taking anticoagulant medication are barred from active participation until their course of treatment concludes. According to available sources, patients receiving a moderate anticoagulant dose typically need to remain on that treatment for at least six weeks. When the clot turns out to be small enough, physicians may start treatment with anti-inflammatory medication alone, keeping the patient under close observation throughout. When a clot migrates — as physicians described occurring in Hurts' situation — anticoagulant therapy is typically among the treatment options pursued. Anticoagulant therapy spanning approximately three months would become the recommended path forward should the clot show signs of deterioration. People close to the team view Hurts as a week-to-week situation, though physicians elsewhere in the league — none of whom have personally evaluated him — have offered assessments that the blood clot may keep him out for a longer stretch. The club's physician explained to a broadcast outlet that recovery timelines vary according to the injury's dimensions, placement, and blood-work assessment, with a return to play potentially stretching beyond six weeks depending on what those evaluations reveal.

Jalen Hurts Blood Clot: Eagles Not Planning Injured Reserve, Seeking Medical Opinions

Related Posts

Jalen Hurts Blood Clot: Eagles Not Planning Injured Reserve, Seeking Medical Opinions

Related Posts